APA (7th ed.) Citation

Forsythe, E., Haws, R. M., Argente, J., Beales, P., Martos-Moreno, G. Á., Dollfus, H., . . . Haqq, A. M. (2023). Quality of life improvements following one year of setmelanotide in children and adult patients with Bardet–Biedl syndrome: Phase 3 trial results. Orphanet Journal of Rare Diseases, 18(1), 1. https://doi.org/10.1186/s13023-022-02602-4

Chicago Style (17th ed.) Citation

Forsythe, Elizabeth, et al. "Quality of Life Improvements Following One Year of Setmelanotide in Children and Adult Patients with Bardet–Biedl Syndrome: Phase 3 Trial Results." Orphanet Journal of Rare Diseases 18, no. 1 (2023): 1. https://doi.org/10.1186/s13023-022-02602-4.

MLA (9th ed.) Citation

Forsythe, Elizabeth, et al. "Quality of Life Improvements Following One Year of Setmelanotide in Children and Adult Patients with Bardet–Biedl Syndrome: Phase 3 Trial Results." Orphanet Journal of Rare Diseases, vol. 18, no. 1, 2023, p. 1, https://doi.org/10.1186/s13023-022-02602-4.